CAPRICOR THERAPEUTICS, INC.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 17, 2026 (22 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 14, 2026 | B. Riley Securities | upgrade | Neutral → Buy | — | 55% |
| Sep 1, 2026 | Piper Sandler | upgrade | Neutral → Overweight | — | 54% |
| Aug 14, 2026 | Cantor Fitzgerald | upgrade | Neutral → Overweight | — | 50% |
| Jul 31, 2026 | Jones Trading | downgrade | Buy → Hold | — | 50% |
| Jul 30, 2026 | Piper Sandler | downgrade | Overweight → Neutral | — | 54% |
| Jul 30, 2026 | Cantor Fitzgerald | downgrade | Overweight → Neutral | — | 50% |
| Jul 30, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| May 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 13, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Mar 13, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Mar 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Dec 15, 2025 | B. Riley Securities | reiterate | Buy → Buy | $50 | 55% |
| Dec 10, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $45 | 54% |
| Dec 8, 2025 | Oppenheimer | maintain | Outperform → Outperform | $54 | 52% |
| Dec 4, 2025 | Maxim Group | maintain | Buy → Buy | $50 | 42% |
| Dec 3, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Nov 12, 2025 | Roth Capital | maintain | Buy → Buy | $13 | 53% |
| Sep 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Sep 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Jul 14, 2025 | Roth Capital | maintain | Buy → Buy | $12 | 53% |
| Jul 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $24 | 44% |
| Jun 26, 2025 | B. Riley Securities | initiate | — → Buy | $21 | 55% |
| Jun 25, 2025 | Jones Trading | maintain | Buy → Buy | $29 | 50% |
| Jun 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Jun 23, 2025 | Oppenheimer | maintain | Outperform → Outperform | $22 | 52% |
| Jun 17, 2025 | Roth Capital | reiterate | Buy → Buy | $31 | 53% |
| Jun 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| May 14, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $30 | 50% |
| Mar 20, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $30 | 50% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Mar 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Jan 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Nov 18, 2024 | Jones Trading | initiate | — → Buy | $40 | 50% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $77 | 44% |
| Nov 14, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $30 | 50% |
| Jul 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| May 17, 2024 | Oppenheimer | initiate | — → Outperform | $14 | 52% |
| May 14, 2024 | Ladenburg Thalmann | maintain | Buy → Buy | $25 | 45% |
| May 14, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $8 | 50% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Apr 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Jan 5, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $8 | 50% |
| Oct 4, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Aug 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Mar 16, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $18 | 44% |
| Oct 26, 2022 | Ladenburg Thalmann | initiate | — → Buy | $15 | 45% |
| Jan 31, 2022 | HC Wainwright & Co. | maintain | — → Buy | $18 | 44% |
No cross-platform signals in the last 90 days